Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 4 of the 14 sources its claims cite were checked for support.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with poor prognosis and limited therapeutic options. The incidence of IPF increases with age, and ageing-related mechanisms such as cellular senescence have been proposed as pathogenic drivers. The lung alveolar epithelium represents a major site of tissue injury in IPF and senescence of this cell population is probably detrimental to lung repair. However, the potential pathomechanisms of alveolar epithelial cell senescence and the impact of senolytic drugs on senescent lung cells and fibrosis remain unknown. Here we demonstrate that lung epithelial cells exhibit increased P16 and P21 expression as well as senescence-associated β-galactosidase activity in experimental and human lung fibrosis tissue and primary cells. Primary fibrotic mouse alveolar epithelial type (AT)II cells secreted increased amounts of senescence-associated secretory phenotype (SASP) factors in vitro , as analysed using quantitative PCR, mass spectrometry and ELISA. Importantly, pharmacological clearance of senescent cells by induction of apoptosis in fibrotic ATII cells or ex vivo three-dimensional lung tissue cultures reduced SASP factors and extracellular matrix markers, while increasing alveolar epithelial markers . These data indicate that alveolar epithelial cell senescence contributes to lung fibrosis development and that senolytic drugs may be a viable therapeutic option for IPF.
Overview
CoChat Summary
TL;DR
In human IPF and bleomycin-induced murine lung fibrosis, alveolar epithelial cells show increased senescence markers and a profibrotic SASP. Senolytic dasatinib+quercetin treatment depleted senescent ATII cells and ex vivo 3D lung tissue cultures, reduced SASP/extracellular matrix markers, and increased alveolar epithelial markers.
Key findings
- IPF lung homogenates had increased P16 mRNA (mean±sd ΔCt donor −1.91±0.74 versus IPF 0.74±0.40, p<0.01), while P21 mRNA was unchanged; P16 and P21 protein were increased by Western blot, and P16/P21 localized largely to proSP-C+ KRT7+ ATII cells in IPF lungs.
- In bleomycin-treated mice, P16 and P21 were upregulated (day 14 P16: PBS −5.66±0.34 versus Bleo −4.33±0.21; P21: PBS −0.64±0.22 versus Bleo 1.42±0.22; p<0.001); SA-β-galactosidase activity increased in fibrotic 3D-LTCs, and senescence-associated gene enrichment was found in fibrotic pmATII cells but not whole lung or pmFb.
- Freshly isolated fibrotic EpCAM+ pmATII cells had increased SA-β-galactosidase; after 48 h culture this remained 2.45±0.45-fold over healthy cells, with increased P16/P21, H3K9me3 foci, and Spp1/Mmp2; secretome analysis found 52% of detected SASP components upregulated >1.5-fold and 10% downregulated.
- Dasatinib+quercetin reduced senescent cells, P16, SASP factors (Mmp12, Serpine1, Spp1), ECM components (Collagen1a1, Collagen5a3, Fibronectin), IL-6 (DMSO 3.95±0.81-fold over control versus DQ 1.34±0.65-fold), and Wisp1 (DMSO 2.10±0.91 versus DQ 0.71±0.26), while increasing E-cadherin, Sftpc, Sftpa, and SP-C in ATII cells and 3D-LTCs.
Methods
- Human explanted IPF and donor lung tissue plus primary human ATII cells; mouse bleomycin-induced lung fibrosis (2 U·kg−1 body weight, sacrificed at day 7, 14, or 21) versus PBS controls; primary mouse ATII cells and three-dimensional lung tissue cultures (3D-LTCs).
- Senescence assessed by qPCR for P16/P21, Western blotting, immunohistochemistry, SA-β-galactosidase staining/flow cytometry, H3K9me3 foci, and gene set enrichment analysis; SASP assessed by quantitative PCR, mass spectrometry, and ELISA.
- Senolytic treatment used dasatinib and quercetin; apoptosis assessed by cleaved caspase 3 and annexin V; statistics used t-tests, paired t-tests, one-way ANOVA with Newman–Keuls multiple comparison, and Pearson correlation, with p<0.05 considered significant.
Limitations
- Stated: lack of reliable and specific mouse P16 antibodies prevented analysis of P16 at the protein level; future in vivo studies targeting specific senescent cell populations are needed; human lung tissue confirmation is needed; other cell types, such as fibroblasts, are likely also affected by senolytic treatment in 3D-LTCs.
- Stated/evident: the therapeutic evidence is largely in vitro and ex vivo, so in vivo efficacy and the causal contribution of alveolar epithelial senescence to human IPF remain to be established.
- Evident: senolytic effects are not cell-type-specific in the ex vivo system, and the text does not report human cohort sample sizes or detailed clinical characteristics.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![FIGURE 2 Senescence markers are upregulated in experimental lung fibrosis. Mice were instilled with PBS or bleomycin (Bleo) and sacrificed at the timepoints indicated. a) Gene expression of P16 and P21 in lung homogenates of mice sacrificed at day 7, 14 or 21 was measured using quantitative PCR and normalised to Hprt. Change in cycle threshold (ΔCt) is presented as mean±sem; n=3 for PBS and n=5 for Bleo. Statistical significance was tested using one-way ANOVA followed by Newman–Keuls' multiple comparison test. b) Immunoblot of P21 protein in mouse whole-lung homogenates of mice treated with PBS or Bleo and sacrificed after 7 or 14 days. β-Actin was used as a loading control. Respective sizes of marker are indicated. Data were quantified and normalised to loading control. Data are presented as mean±sem; n=9. Statistical significance was tested using one-way ANOVA followed by Newman-Keuls' multiple comparison test. c, d) Three-dimensional lung tissue cultures (3D-LTCs) were obtained from mice instilled with PBS or Bleo and sacrificed at day 14. 3D-LTCs were stained for senescence-associated β-galactosidase activity and c) macroscopic images and d) microscopic (magnification of 200× or 400×) images were taken. Epithelial cells are marked by arrows. e) Enrichment of senescence-associated genes [31] in microarray data of i) whole lung [32] (GSE16846), ii) mouse fibroblasts [33] (GSE42564) or iii) primary mouse (pm) alveolar epithelial type (AT)II cells [26] of mice with experimental lung fibrosis induced by Bleo. FDR: false discovery rate; FWER: family-wise error rate. *: p<0.05; ***: p<0.001.](https://figures.cochat.ai/paper-figures/56638935b27e4e57934b4d3b372306d6/senolytic-drugs-target-alveolar-epithelial-cell-function-and-attenuate-figure-2.jpg)
![FIGURE 3 Senescence markers are upregulated in alveolar epithelial type (AT)II cells in experimental lung fibrosis. Mice were instilled with either PBS or bleomycin (Bleo). At day 14 after instillation, mice were sacrificed and primary mouse (pm)ATII cells were isolated. a) Immunofluorescence staining of fibrotic or nonfibrotic pmATII cells on cover slips for epithelial cell marker expression at day 2 after isolation. Fluorescent images represent a 400× magnification. b) pmATII cells were analysed for epithelial cell adhesion molecule (EpCAM) positivity and senescence-associated (SA)-β-galactosidase activity by fluorescence-activated cell sorting (FACS) directly after isolation. Representative dot blots of the EpCAM+ population are shown for PBS and Bleo, as well as quantifications of percentages of senescent cells of the EpCAM+ population. Means were compared to time-matched PBS controls using unpaired t-tests; n=3. c) pmATII cells (day 2) were analysed for SA-β-galactosidase activity using FACS. Representative dot blots are shown for PBS and Bleo pmATII cells incubated with C12FDG or respective controls, a representative histogram comparing PBS and Bleo pmATII cells incubated with C12FDG as well as quantifications of percentages of senescent cells normalised to respective PBS control. Means were compared to time-matched PBS controls using unpaired t-tests; n=3. d) pmATII cells (day 2) were stained for SA-β-galactosidase activity and blue cells and total cells were counted. Representative images and quantitative data normalised to respective PBS controls are shown. Data represent mean±sem. Means were compared to time-matched PBS controls using unpaired t-tests; n=3. e) Gene expression of senescence-associated genes in freshly isolated pmATII cells from PBS- or Bleo-treated mice was measured using quantitative PCR. Data were normalised to Hprt. Change in threshold cycle (ΔCt) is presented as mean±sem; n=3–4 for PBS and n=8 for Bleo. Means were compared to time-matched PBS controls using unpaired t-tests. f–h) pmATII cells isolated from PBS- or Bleo-treated mice were plated onto plastic tissue culture plates. After 48 h of culture, the supernatant was collected and analysed using mass spectrometry proteomics. The senescence-associated secretory phenotype (SASP) list [9] was compared to the list of secreted proteins (1.5-fold upregulated or downregulated). f) A Venn diagram (BioVenn; [38]) showing the overlap of SASP proteins with the up-/downregulated proteins in the pmATII supernatant. g) Percentage of detected SASP factors that are upregulated (>1.5-fold) or downregulated (<-1.5-fold) or not changed. h) List of upregulated SASP components >1.5-fold Bleo/PBS. CK: cytokeratin; ZO: zona occludens; SMA: smooth muscle actin. *: p<0.05; ***: p<0.001.](https://figures.cochat.ai/paper-figures/6ca25af067a345fc9715e0545f80b71a/senolytic-drugs-target-alveolar-epithelial-cell-function-and-attenuate-figure-3.jpg)




Verification
Claims the paper makes
2 Valid · 0 Not valid · 3 Not checked · 60 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“cellular senescence has been linked to the pathogenesis of chronic lung diseases such as chronic obstructive pulmonary disease [14, 15] or IPF [16–20].”
§ Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo > Introduction
What the sources say
- Not checked yetcites [14] source
- Not checked yetcites [15] source
- Supportedcites [16] Disayabutr, 2016, miR-34 miRNAs regulate cellular senescence in type II alveolar epithelial cells of patients with idiopathic pulmonary fibrosis, PLoS One source
This source is cited for the IPF portion of the sentence, not COPD. The Introduction associates cellular senescence with IPF, and the Discussion calls it a pathologic feature of IPF and reports elevated senescence markers in IPF lung cells. Page numbers are not available in the supplied copy. (LLM, conf=0.94)
- Supportedcites [17] Hecker, 2014, Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance, Sci Transl Med source
This source supports the IPF portion of the sentence, to which the [16–20] citations are attached. The Results section reports a senescent cellular phenotype in fibroblastic foci of human IPF lungs, and the Discussion explicitly describes a link between cellular senescence and IPF. The COPD portion is cited separately. (LLM, conf=0.92)
- Not checked yetcites [18] source
- Not checked yetcites [19] source
- Not checked yetcites [20] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition to lung fibroblasts, evidence has emerged that alveolar epithelial cells can become senescent in IPF [16, 20, 24].”
§ Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo > Introduction
What the sources say
- Supportedcites [16] Disayabutr, 2016, miR-34 miRNAs regulate cellular senescence in type II alveolar epithelial cells of patients with idiopathic pulmonary fibrosis, PLoS One source
The Results section (‘Expression of senescence markers in isolated type II AECs’) reports senescence markers and SA-βgal activity in type II alveolar epithelial cells from IPF lungs. The Discussion likewise concludes that these cells are a major source of senescent cells in IPF lung. (LLM, conf=0.94)
- Not checked yetcites [20] source
- Supportedcites [24] Naikawadi, 2016, Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis, JCI Insight source
The Introduction reports that type II alveolar epithelial cells in IPF lungs express senescence markers. The Discussion likewise identifies expression of molecular markers of senescence as a defect in IPF type II alveolar epithelial cells. These passages support the cited claim. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Primary fibrotic mouse alveolar epithelial type (AT)II cells secreted increased amounts of senescence-associated secretory phenotype (SASP) factors in vitro, as analysed using quantitative PCR, mass spectrometry and ELISA.”
§ Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“while no or only sporadic staining for P16 and P21 was observed in donor lungs (figure 1d; arrows).”
§ Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo > Results > Senescence marker expression is upregulated in the lung epithelium in IPF
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 48 h of culture, fibrotic ATII cells maintained an increase of 2.45±0.45-fold in SA-β-galactosidase staining over healthy cells (figure 3c).”
§ Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo > Results > Increased senescence of ATII cells in experimental lung fibrosis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
37 more claims
Create a free account to see all 65 claims and to verify the 10 references still open.
- It may state two separate claims as one. 23
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [32]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Preclinical evidence suggests that senescent fibroblasts and alveolar epithelial cells contribute to pulmonary fibrosis and supports cellular senescence as a potential target for treatment for bleomycin-induced lung injury model of pulmonary fibrosis that may be translationally relevant to humans.5,10,11”
From Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Cited by
TGF-β signaling in health and disease
Massagué, J., & Sheppard, D. (2023) · Cell · doi:10.1016/j.cell.2023.07.036 · Cited by 890
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Strunz, M., Simon, L. M., Ansari, M., Kathiriya, J. J., Angelidis, I., Mayr, C. H., Tsidiridis, G., Lange, M., Mattner, L. F., Yee, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17358-3 · Cited by 728
Self-citationShared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Self-citationEvasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
Barnes, P. J., Baker, J., & Donnelly, L. E. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1975tr · Cited by 555
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
Yao, C., Guan, X., Carraro, G., Parimon, T., Liu, X., Huang, G., Mulay, A., Soukiasian, H. J., David, G., Weigt, S. S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1274oc · Cited by 520
The aging lung: Physiology, disease, and immunity
Schneider, J. L., Rowe, J. H., Garcia-de-Alba, C., Kim, C. F., Sharpe, A. H., & Haigis, M. C. (2021) · Cell · doi:10.1016/j.cell.2021.03.005 · Cited by 500
“Ex vivo, D+Q decreases fibrotic markers and increases epithelial markers, with reduction of SASP factors and ECM components (Lehmann et al., 2017).”
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 450
Source of chronic inflammation in aging
Sanada, F., Taniyama, Y., Muratsu, J., Otsu, R., Shimizu, H., Rakugi, H., & Morishita, R. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00012 · Cited by 413
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Parimon, T., Yao, C., Stripp, B. R., Noble, P. W., & Chen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072269 · Cited by 375
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
“In other studies, an increase in p16 and p21 concentrations in AEC type II from pulmonary tissues in IPF patients might be associated with higher disease severity, possibly as a result of an impaired transport of carbon monoxide [78].”
BackgroundRadiation-induced lung injury: current evidence
Arroyo-Hernández, M., Maldonado, F., Lozano-Ruiz, F., Muñoz-Montaño, W., Nuñez-Baez, M., & Arrieta, O. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01376-4 · Cited by 374
Jun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Aged-senescent cells contribute to impaired heart regeneration
Lewis‐McDougall, F. C., Ruchaya, P. J., Domenjo‐Vila, E., Shin Teoh, T., Prata, L., Cottle, B. J., Clark, J. E., Punjabi, P. P., Awad, W., Torella, D., et al. (2019) · Aging Cell · doi:10.1111/acel.12931 · Cited by 317
Targeting senescent cells in translational medicine
Paez‐Ribes, M., González‐Gualda, E., Doherty, G. J., & Muñoz‐Espín, D. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810234 · Cited by 293
“…senescence; ROS, reactive oxygen species; SASP, senescence-associated secretory phenotype; TFs, transcription factors; TS, tumour suppressor. ª 2019 The Authors EMBO Molecular Medicine 11: e10234 | 2019 5 of 19 fibrotic lungs with D + Q reduced senescence and fibrosis markers (Lehmann et al, 2017).”
BackgroundTherapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Nambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104481 · Cited by 298
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Bueno, M., Calyeca, J., Rojas, M., & Mora, A. L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101509 · Cited by 275
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Borghesan, M., Hoogaars, W. M. H., Varela-Eirin, M., Talma, N., & Demaria, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.002 · Cited by 267
“In IPF models, clearance of senescent epithelial cells in INK-ATTACmice or by the senolytics D+Q, improves overall pulmonary function and elastance [77] as seen also by reductions in ECM deposition and the associated profibrotic SASP [78].”
BackgroundAging, Cellular Senescence, and Alzheimer’s Disease
Liu, R.-M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041989 · Cited by 267
Hypoxia as a driver of resistance to immunotherapy
Kopecka, J., Salaroglio, I. C., Perez-Ruiz, E., Sarmento-Ribeiro, A. B., Saponara, S., De Las Rivas, J., & Riganti, C. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100787 · Cited by 246
The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., & Pardo, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109482 · Cited by 225
D’Agnillo, F., Walters, K.-A., Xiao, Y., Sheng, Z.-M., Scherler, K., Park, J., Gygli, S., Rosas, L. A., Sadtler, K., Kalish, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7790 · Cited by 237
Tian, Y., Li, H., Qiu, T., Dai, J., Zhang, Y., Chen, J., & Cai, H. (2019) · Aging Cell · doi:10.1111/acel.12858 · Cited by 198
“And anti‐senescence treatment might be beneficial to blocking the process of pulmonary fibrosis (Lehmann et al., 2017).”
BackgroundHohmann, M. S., Habiel, D. M., Coelho, A. L., Verri, W. A., & Hogaboam, C. M. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0289oc · Cited by 202
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200
“When given together, these two compounds were shown to selectively kill senescent primary preadipocyte cells and senescent human umbilical vein endothelial cells (HUVECs) in tissue culture, as well as reduce senescent cell signature in a set of pathological conditions (30, 31, 47, 58).”
BackgroundSenescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.03.008 · Cited by 195
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Tzouvelekis, A., Gomatou, G., Bouros, E., Trigidou, R., Tzilas, V., & Bouros, D. (2019) · Chest · doi:10.1016/j.chest.2019.04.114 · Cited by 176
Borok, Z., Horie, M., Flodby, P., Wang, H., Liu, Y., Ganesh, S., Firth, A. L., Minoo, P., Li, C., Beers, M. F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0451oc · Cited by 170
Inhibition of LTβR signalling activates WNT-induced regeneration in lung
Conlon, T. M., John-Schuster, G., Heide, D., Pfister, D., Lehmann, M., Hu, Y., Ertüz, Z., Lopez, M. A., Ansari, M., Strunz, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2882-8 · Cited by 179
Self-citationMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“related disease is an attractive concept, and no overt side effects have been recorded in control mice or ex vivo lung tissues when administered in the context of pulmonary fibrosis (Lehmann et al., 2017; Schafer et al., 2017), reports of undesirable side-effects have been recorded in human cancer patients, including…”
BackgroundInfluentialPotential role of senescent macrophages in radiation-induced pulmonary fibrosis
Su, L., Dong, Y., Wang, Y., Wang, Y., Guan, B., Lu, Y., Wu, J., Wang, X., Li, D., Meng, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03811-8 · Cited by 167
Zhang, Y., Huang, W., Zheng, Z., Wang, W., Yuan, Y., Hong, Q., Lin, J., Li, X., & Meng, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.013 · Cited by 160
Regulation of epithelial transitional states in murine and human pulmonary fibrosis
Wang, F., Ting, C., Riemondy, K. A., Douglas, M., Foster, K., Patel, N., Kaku, N., Linsalata, A., Nemzek, J., Varisco, B. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165612 · Cited by 162
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
Rana, T., Jiang, C., Liu, G., Miyata, T., Antony, V., Thannickal, V. J., & Liu, R.-M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0071oc · Cited by 157
Hecker, L. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00275.2017 · Cited by 153
“By using an ex vivo three-dimensional lung tissue culture model, a combination of senolytic drugs, dasatinib and quercetin (DQ), resulted in clearance of senescent cells and reduced senescence-associated secretory phenotype factors and ECM markers, which also promoted increased alveolar epithelial markers (79).”
MethodTargeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
Lv, J., Wang, Z., Qu, Y., Zhu, H., Zhu, Q., Tong, W., Bao, L., Lv, Q., Cong, J., Li, D., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00258-1 · Cited by 167
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
Saito, S., Alkhatib, A., Kolls, J. K., Kondoh, Y., & Lasky, J. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.62 · Cited by 148
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Zank, D. C., Bueno, M., Mora, A. L., & Rojas, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00010 · Cited by 150
The Role of Epithelial Damage in the Pulmonary Immune Response
Burgoyne, R. A., Fisher, A. J., & Borthwick, L. A. (2021) · Cells · doi:10.3390/cells10102763 · Cited by 165
Alsafadi, H. N., Uhl, F. E., Pineda, R., Bailey, K. E., Rojas, M. M., Wagner, D. E., & Königshoff, M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0276tr · Cited by 151
“One such hallmark, cellular senescence (71), was recently shown to be present in PCLS from an experimental lung fibrosis model, and senolytics were successfully applied in this model to target senescent cells and attenuate fibrosis (70).”
BackgroundSelf-citationSummer, R., Shaghaghi, H., Schriner, D., Roque, W., Sales, D., Cuevas-Mora, K., Desai, V., Bhushan, A., Ramirez, M. I., & Romero, F. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00244.2018 · Cited by 143
“Moreover, recent studies have shown that targeting senescent cells for destruction can be quite effective in ameliorating experimentally induced respiratory conditions, highlighting a potential role for antisenescent approaches in the treatment of lung disease (12, 18).”
BackgroundTargeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
Estornut, C., Milara, J., Bayarri, M. A., Belhadj, N., & Cortijo, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794997 · Cited by 161
“…January 2022 | Volume 12 | Article 79499712 human fibroblasts demonstrated that treatment with this senolytic combination attenuates fibrotic mediator expression, such as senescence-associated secretory phenotype factor and extracellular matrix markers (Lehmann et al., 2017; Schafer et al., 2017).”
BackgroundLehmann, M., Buhl, L., Alsafadi, H. N., Klee, S., Hermann, S., Mutze, K., Ota, C., Lindner, M., Behr, J., Hilgendorff, A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0876-y · Cited by 138
“phenotypic and functional changes upon fibrotic lung injury [4, 5], including endoplasmatic reticulum stress [6], mitochondrial dysfunction [7], or senescence [8], Moreover, these cells have been reported to release a variety”
Self-citationNess, K. K., Kirkland, J. L., Gramatges, M. M., Wang, Z., Kundu, M., McCastlain, K., Li-Harms, X., Zhang, J., Tchkonia, T., Pluijm, S. M. F., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.7467 · Cited by 140
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19
Liu, Y., Lv, J., Liu, J., Li, M., Xie, J., Lv, Q., Deng, W., Zhou, N., Zhou, Y., Song, J., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00435-z · Cited by 137
Physiologic Effects of Noninvasive Ventilation
MacIntyre, N. R. (2019) · Respiratory Care · doi:10.4187/respcare.06635 · Cited by 143
Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality
Kulkarni, U., Zemans, R. L., Smith, C. A., Wood, S. C., Deng, J. C., & Goldstein, D. R. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0115-3 · Cited by 138
Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis
Wiley, C. D., Brumwell, A. N., Davis, S. S., Jackson, J. R., Valdovinos, A., Calhoun, C., Alimirah, F., Castellanos, C. A., Ruan, R., Wei, Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130056 · Cited by 132
Lelarge, V., Capelle, R., Oger, F., Mathieu, T., & Le Calvé, B. (2024) · npj Aging · doi:10.1038/s41514-024-00138-4 · Cited by 140
Chronic WNT/β-catenin signaling induces cellular senescence in lung epithelial cells
Lehmann, M., Hu, Q., Hu, Y., Hafner, K., Costa, R., van den Berg, A., & Königshoff, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109588 · Cited by 147
“In accordance, ATII cells have been shown to exhibit cellular senescence and SASP secretion in IPF and further show signs of telomere attrition and oxidative stress [14,46].”
BackgroundMethodInfluentialSelf-citationCecchini, M. J., Hosein, K., Howlett, C. J., JOSEPH, M. G., & Mura, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0857-1 · Cited by 141
“Furthermore, senescence in IPF occurs prevalently in epithelial cells [35], as confirmed on IHC studies, and these may not account for much of the overall gene expression signal in homogenized samples.”
BackgroundRegulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 128
Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review
Nguyen, H. Q., To, N. H., Zadigue, P., Kerbrat, S., De La Taille, A., Le Gouvello, S., & Belkacemi, Y. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.012 · Cited by 120
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 134
“Accelerating aging, including loss of epithelial progenitor cell function and/or numbers and cellular senescence, is one of the key factors in IPF pathogenesis [40-42].”
BackgroundErratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 128
Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119
“The pathological role of senescent cells in lung fibrosis has been recently demonstrated in mouse models using pharmacological and genetic means [45].”
BackgroundExtracellular Vesicles from Fibroblasts Induce Epithelial-Cell Senescence in Pulmonary Fibrosis
Kadota, T., Yoshioka, Y., Fujita, Y., Araya, J., Minagawa, S., Hara, H., Miyamoto, A., Suzuki, S., Fujimori, S., Kohno, T., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0002oc · Cited by 134
Cell senescence and fibrotic lung diseases
Liu, R.-M., & Liu, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110836 · Cited by 113
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic
Galiana, I., Lozano-Torres, B., Sancho, M., Alfonso, M., Bernardos, A., Bisbal, V., Serrano, M., Martínez-Máñez, R., & Orzáez, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.045 · Cited by 115
The Aging Lung and Idiopathic Pulmonary Fibrosis
Gulati, S., & Thannickal, V. J. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.02.008 · Cited by 111
Cellular senescence: a double-edged sword in cancer therapy
Xiao, S., Qin, D., Hou, X., Tian, L., Yu, Y., Zhang, R., Lyu, H., Guo, D. S., Chen, X., Zhou, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1189015 · Cited by 143
“According to the report, the senolytic cocktail of D+Q was effective in reducing injury idiopathic pulmonary fibrosis (IPF) and against senescent alveolar epithelial cell types by selectively eliminating senescent cells (91, 92).”
BackgroundManaging malnutrition in COPD: A review
Keogh, E., & Williams, E. M. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106248 · Cited by 129
Parimon, T., Yao, C., Habiel, D. M., Ge, L., Bora, S. A., Brauer, R., Evans, C. M., Xie, T., Alonso-Valenteen, F., Medina-Kauwe, L. K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129359 · Cited by 104
“Wnt/β-catenin signaling is dysregulated in the aged lung and promotes senescence, and a pathogenic feature of reprogrammed fibrotic lung epithelial cells is cellular senescence (8, 9, 48, 60, 61).”
BackgroundSelf-citationSenescent cells and macrophages: key players for regeneration?
Elder, S. S., & Emmerson, E. (2020) · Open Biology · doi:10.1098/rsob.200309 · Cited by 117
Cellular senescence and radiation-induced pulmonary fibrosis
He, Y., Thummuri, D., Zheng, G., Okunieff, P., Citrin, D. E., Vujaskovic, Z., & Zhou, D. (2019) · Translational Research · doi:10.1016/j.trsl.2019.03.006 · Cited by 103
Brightling, C. E., Gaga, M., Inoue, H., Li, J., Maspero, J. F., Wenzel, S. E., Maitra, S., Lawrence, D., Brockhaus, F., Lehmann, T., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30412-4 · Cited by 114
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
Kato, K., Logsdon, N. J., Shin, Y.-J., Palumbo, S., Knox, A., Irish, J. D., Rounseville, S. P., Rummel, S. R., Mohamed, M., Ahmad, K., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0092oc · Cited by 113
“Furthermore, recent studies have also suggested that alveolar epithelial cell senescence contributes to IPF pathogenesis (27, 52).”
BackgroundMitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts
Schuliga, M., Pechkovsky, D. V., Read, J., Waters, D. W., Blokland, K. E. C., Reid, A. T., Hogaboam, C. M., Khalil, N., Burgess, J. K., Prêle, C. M., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13855 · Cited by 97
“Recent evidence suggests that the senescence of type II alveolar epithelial cells (AECIIs) in IPF impairs re‐epithelialization following injury, triggering a cascade of events that lead to fibrosis.(14,15) Senescent lung fibroblasts (LFs) are also highly likely have a role in IPF, exhibiting myofibroblast‐like charact…”
BackgroundDePianto, D. J., Heiden, J. A. V., Morshead, K. B., Sun, K.-H., Modrusan, Z., Teng, G., Wolters, P. J., & Arron, J. R. (2021) · JCI Insight · doi:10.1172/jci.insight.143626 · Cited by 92
“Consistent with previous reports (26, 27), CDKN2A gene expression was significantly elevated in lungs from IPF patients compared with controls (Figure 1A) from lung biopsy microarray data (Gene Expression Omnibus [GEO] GSE53845) (7).”
Cammarota, G., Sguazzotti, I., Zanoni, M., Messina, A., Colombo, D., Vignazia, G. L., Vetrugno, L., Garofalo, E., Bruni, A., Navalesi, P., et al. (2019) · Respiratory Care · doi:10.4187/respcare.06803 · Cited by 93
Zhang, C., Zhong, W., Liu, Y., Duan, J., Jiang, N., Yang, H., Ma, S., Jin, L., Hong, J., Zhou, Y., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102765 · Cited by 104
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis
Chin, C., Ravichandran, R., Sanborn, K., Fleming, T. P., Wheatcroft, S. B., Kearney, M. T., Tokman, S., Walia, R., Smith, M. A., Flint, D. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100945 · Cited by 106
“Alveolar epithelial cell senescence is evident in IPF and in a variety of experimental models of lung fibrosis.(45) Development of senescence biomarkers and senolytic drugs is an active area of research for age-related diseases.”
The redox-senescence axis and its therapeutic targeting
Ngoi, N. Y., Liew, A. Q., Chong, S. J. F., Davids, M. S., Clement, M.-V., & Pervaiz, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102032 · Cited by 88
Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis
Parimon, T., Chen, P., Stripp, B. R., Liang, J., Jiang, D., Noble, P. W., Parks, W. C., & Yao, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2023 · Cited by 110
Cellular Senescence in the Lung: The Central Role of Senescent Epithelial Cells
Hansel, C., Jendrossek, V., & Klein, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093279 · Cited by 93
Hernández‐Terán, A., Mejía-Nepomuceno, F., Herrera, M. T., Barreto, O., García, E., Castillejos-López, M. D. J., Boukadida, C., Matías‐Florentino, M., Rincón-Rubio, A., Ávila‐Ríos, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00851-0 · Cited by 86
Autophagy Reprograms Alveolar Progenitor Cell Metabolism in Response to Lung Injury
Li, X., Wu, J., Sun, X., Wu, Q., Li, Y., Li, K., Zhang, Q., Li, Y., Abel, E. D., & Chen, H. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.01.008 · Cited by 82
“A high level of ROS would likely induce AT2 cell senescence in lung fibrotic injury (Lehmann et al., 2017).”
BackgroundCellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
Knoppert, S. N., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Falke, L. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00770 · Cited by 83
Cellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
“Based on their known targets, a combination therapy with Dasatinib and Quercetin not only was proved to clear senescent cells in vivo in chronologically aged progeroid mice, decreasing irradiation-induced cardiac dysfunction, but also impaired senescence and SASP markers (IL-6, IL8, MCP-1, PAI-1 and GM-CSF) in isolate…”
BackgroundCellular cross-talks in the diseased and aging heart
Wagner, J. U. G., & Dimmeler, S. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.152 · Cited by 84
Zhang, L., Zhang, J., Zhang, Y., Fei, C., Wang, L., Yi, Z.-W., & Zhang, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108756 · Cited by 75
Bellíssimo-Rodrigues, W. T., Menegüeti, M. G., Gaspar, G. G., de Souza, H. C. C., Auxiliadora‐Martins, M., Basile-Filho, A., Martínez, R., & Bellissimo‐Rodrigues, F. (2018) · International Dental Journal · doi:10.1111/idj.12397 · Cited by 82
CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging
Cui, H., Xie, N., Banerjee, S., Dey, T., Liu, R.-M., Antony, V. B., Sanders, Y. Y., Adams, T. S., Gómez, J. L., Thannickal, V. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2151oc · Cited by 76
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Wei, L., Schuliga, M. J., Jaffar, J., Westall, G. P., Hansbro, P. M., Prêle, C. M., Mutsaers, S. E., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0328oc · Cited by 77
Senescence in tissue samples of humans with age-related diseases: A systematic review
Tuttle, C. S. L., Luesken, S. W. M., Waaijer, M. E. C., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101334 · Cited by 64
“, 2012), Type II cells (Aoshiba et al., 2012; Disayabutr et al., 2016; Lehmann et al., 2017; Tsuji et al., 2006, 2010), Clara cells (Zhou et al.”
Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis
Chakraborty, A., Mastalerz, M., Ansari, M., Schiller, H. B., & Staab-Weijnitz, C. A. (2022) · Cells · doi:10.3390/cells11061050 · Cited by 68
“Notably, senescent epithelial cells from fibrotic tissue have been shown to secrete proinflammatory and profibrotic molecules as components of their senescence-associated secretory phenotype (SASP) [97], suggesting that they may be a direct driver of disease pathogenesis.”
BackgroundSelf-citationNADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 70
Cellular Senescence in Idiopathic Pulmonary Fibrosis
Kellogg, D. L., Kellogg, D. L., Musi, N., & Nambiar, A. M. (2021) · Current Molecular Biology Reports · doi:10.1007/s40610-021-00145-4 · Cited by 67
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Korfei, M., Mahavadi, P., & Guenther, A. (2022) · Cells · doi:10.3390/cells11101626 · Cited by 72
Self-citationZhang, C., Duan, J., Yang, H., Sun, C., Zhong, W., Tao, J., Guan, X., Jiang, H., Hammock, B. D., Hwang, S. H., et al. (2019) · FEBS Journal · doi:10.1111/febs.15105 · Cited by 65
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 61
“Depletion of senescent AT2 cells by senolytic drugs decreases fibrotic markers and increases epithelial cell marker expression (Lehmann et al., 2017).”
Background
Metadata
- Authors
- Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., Wagner, D. E., Günther, A., & Königshoff, M.
- Affiliations
- Helmholtz Munich (DE)
- Justus-Liebig-Universität Gießen (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2017-08
- Volume
- 50
- Issue
- 2
- Pages
- 1602367
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC5593348
- OpenAlex
- W2744177930
- Cited by
- 403
- References
- 64
- Citations by year
- 2026: 32 · 2025: 33 · 2024: 34 · 2023: 40 · 2022: 33 · 2021: 81 · 2020: 57 · 2019: 45 · 2018: 43 · 2017: 5
- FWCI
- 33.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by-nc)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Whitaker International Scholar Fellowship
- Helmholtz Munich Postdoctoral Program
- Helmholtz Association
- German Center of Lung Research
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- senolytics, idiopathic pulmonary fibrosis, cellular senescence, alveolar epithelial cells, alveolar type II cells, senescence-associated secretory phenotype, senolytic therapy, extracellular matrix, pulmonary fibrosis, apoptosis, p16, p21, senescence-associated β-galactosidase
- MeSH terms
- Animals, Humans, Lung, Biomarkers, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cyclin-Dependent Kinase Inhibitor p21, Mice, Idiopathic Pulmonary Fibrosis, Alveolar Epithelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.